Interview with Andreas Plückthun, Ph.D., Professor and Director, Department of Biochemistry, University of Zürich, Switzerland

The Laboratory of Andreas Plückthun studies the creation of new proteins and protein variants. The purpose of this work is to use such engineered proteins to enable research and applications which have been very difficult or even impossible so far. Example endeavors in his lab include the creation of new engineered binding proteins to inhibit other proteins or to kill tumor cells, or the stabilization of proteins so that they can be studied structurally and biophysically.

Watch this interview in which Andreas shares his views on antibody research and exciting developments in his lab.


Andreas Plückthun is one of the scientific advisory board members and organizers of the Antibody Engineering & Therapeutics conference scheduled for December 7-10, 2015 in San Diego. He will also be chairing a session at the event on “New Aspects of Prodrug Targeting” and giving a presentation at the event titled “Protein Engineering Approaches to Protein Toxic Prodrugs”

Want to learn more? Download the brochure or register now. 

Share this article with your social network, just click below to share now!

Share |